Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2762 |
|
Actual shortage: | 228 (8%) | |
Anticipated shortage: | 1 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2524 (91%) | |
Discontinuation Reports |
256 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 253 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
13 (6%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-VENLAFAXINE XR | 75MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2019-09-05 | 2020-02-08 | 93146 |
TEVA-PREGABALIN | 75MG | CAPSULE | Resolved | 2020-03-26 | 2020-07-10 | 109638 |
TEVA-CLOPIDOGREL | 75MG | TABLET | Resolved | 2020-09-24 | 2020-11-26 | 124968 |
TEVA-CLOPIDOGREL | 75MG | TABLET | Resolved | 2020-10-22 | 2020-12-17 | 126912 |
TEVA-CLOPIDOGREL | 75MG | TABLET | Resolved | 2020-10-22 | 2021-04-21 | 126942 |
TEVA-CLOPIDOGREL | 75MG | TABLET | Resolved | 2021-03-25 | 2021-05-13 | 136317 |
TEVA-CLOPIDOGREL | 75MG | TABLET | Resolved | 2021-03-25 | 2021-04-29 | 136332 |
TEVA-CLOPIDOGREL | 75MG | TABLET | Resolved | 2021-09-02 | 2022-01-20 | 145124 |
TEVA-CLOPIDOGREL | 75MG | TABLET | Resolved | 2021-09-30 | 2022-01-20 | 146446 |
TEVA-CLOPIDOGREL | 75MG | TABLET | Resolved | 2022-01-27 | 2022-11-12 | 153733 |
TEVA-CLOPIDOGREL | 75MG | TABLET | Resolved | 2022-04-21 | 2022-11-12 | 159198 |
TEVA-PREGABALIN | 75MG | CAPSULE | Resolved | 2022-06-09 | 2023-06-09 | 162257 |
TEVA-CLOPIDOGREL | 75MG | TABLET | Resolved | 2022-12-01 | 2022-12-22 | 176812 |
TEVA-CLOPIDOGREL | 75MG | TABLET | Resolved | 2023-04-27 | 2023-07-05 | 190752 |
TEVA-IRBESARTAN | 75MG | TABLET | Resolved | 2023-06-08 | 2023-11-03 | 194135 |
TEVA-CLOPIDOGREL | 75MG | TABLET | Resolved | 2023-06-19 | 2023-10-06 | 195566 |
TEVA-IRBESARTAN | 75MG | TABLET | Resolved | 2023-06-19 | 2023-07-05 | 195588 |
TEVA-CLOPIDOGREL | 75MG | TABLET | Resolved | 2023-06-20 | 2023-10-06 | 195803 |
TEVA-CLOPIDOGREL | 75MG | TABLET | Resolved | 2023-06-20 | 2023-10-06 | 195824 |
TEVA-IRBESARTAN | 75MG | TABLET | Resolved | 2024-01-25 | 2024-04-01 | 217234 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63937 | ||
DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63940 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-12 | 2018-10-12 | 63952 | ||
GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63967 | ||
GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63970 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64520 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64526 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64529 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64532 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64535 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64544 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64547 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64550 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64553 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64589 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64592 | ||
RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64595 | ||
RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64598 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64615 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64623 |